Literature DB >> 22506090

Control of Extensively Drug-Resistant Tuberculosis (XDR-TB): A Root Cause Analysis.

Jennifer Prah Ruger1.   

Abstract

The threat of global infectious agents has the potential to cripple national and global economies, as the outbreaks of SARS, Avian Flu, H1N1, and XDR-TB have demonstrated. This article offers a Root Cause Analysis (RCA) of one public health case study - the Speaker case of XDR-TB - pinpointing the underlying causal relationships associated with this global health incident and proposing recommendations for preventing its recurrence. An RCA approach identifies corrective actions directed at the root causes of the problem and advances them as necessary to eliminate global contagion with its major international public health risks. To my knowledge, this is the first root cause analysis of a global health problem. The reform this article proposes would be to add a standardized procedure akin to the informed consent process in clinical ethics, but within a shared health governance framework. This approach, addressing infectious agents at their origins or source, is potentially a more effective strategy to reduce uncertainty and avert global health threats.

Entities:  

Year:  2010        PMID: 22506090      PMCID: PMC3324909     

Source DB:  PubMed          Journal:  Glob Health Gov        ISSN: 1939-2389


  12 in total

1.  Bioterrorism, public health, and civil liberties.

Authors:  George J Annas
Journal:  N Engl J Med       Date:  2002-04-25       Impact factor: 91.245

2.  Puppy love: bioterrorism, civil rights, and public health.

Authors:  George J Annas
Journal:  Fla Law Rev       Date:  2003-12

3.  When terrorism threatens health: how far are limitations on personal and economic liberties justified?

Authors:  Lawrence O Gostin
Journal:  Fla Law Rev       Date:  2003-12

4.  Latent tuberculosis infection and BCG vaccination.

Authors:  Lisa Ross; Meredith Goff
Journal:  J Midwifery Womens Health       Date:  2005 Jul-Aug       Impact factor: 2.388

5.  Extensively drug-resistant tuberculosis--United States, 1993-2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-03-23       Impact factor: 17.586

6.  Tuberculosis drug development pipeline: progress and hope.

Authors:  Melvin Spigelman; Stephen Gillespie
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

7.  Ethics and governance of global health inequalities.

Authors:  J P Ruger
Journal:  J Epidemiol Community Health       Date:  2006-11       Impact factor: 3.710

8.  Control of tuberculosis--the law and the public's health.

Authors:  G J Annas
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

9.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.

Authors:  Neel R Gandhi; Anthony Moll; A Willem Sturm; Robert Pawinski; Thiloshini Govender; Umesh Lalloo; Kimberly Zeller; Jason Andrews; Gerald Friedland
Journal:  Lancet       Date:  2006-11-04       Impact factor: 79.321

10.  Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management.

Authors:  Richard D Smith
Journal:  Soc Sci Med       Date:  2006-09-15       Impact factor: 4.634

View more
  4 in total

Review 1.  Whole-genome sequencing in outbreak analysis.

Authors:  Carol A Gilchrist; Stephen D Turner; Margaret F Riley; William A Petri; Erik L Hewlett
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

2.  Global Health Governance at a Crossroads.

Authors:  Nora Y Ng; Jennifer Prah Ruger
Journal:  Glob Health Gov       Date:  2011-06-21

3.  Lessons from Africa: developing a global human rights framework for tuberculosis control and prevention.

Authors:  Tracy Slagle; Mehdi Ben Youssef; Golda Calonge; Yanis Ben Amor
Journal:  BMC Int Health Hum Rights       Date:  2014-12-03

4.  Stretching health diplomacy beyond 'Global' problem solving: Bringing the regional normative dimension in.

Authors:  Andrew F Cooper; Asif B Farooq
Journal:  Glob Soc Policy       Date:  2015-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.